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pre-B migration away from the source of
IL-7. An alternative explanation for why
IRF-4,8 double-deficient mice cannot
produce B cells could come from the ob-
servation that withdrawal of IL-7 from the
culture medium of IRF-4,8 double-defi-
cient pre-B cells gave robust k gene rear-
rangement (Johnson et al., 2008) but no
expression of the BCR on the cell surface
(Ma et al., 2006; Johnson et al., 2008).
This finding could reflect a downstream
dependency on IRF-4 or IRF-8, either for
efficient transcription of the rearranged
light-chain gene itself or of other genes
necessary for efficient light-chain expres-
sion on the cell surface. The observation
that withdrawal of IL-7 induces RAG
expression in pre-B cells raises questions
as to how the presumed inhibition of RAG
expression is circumvented at the earlier
pro-B cell stage, where IL-7 is known to
support growth and maintenance of the
cells. Could it be that a fraction of pro-B
cell precursors transiently and perhaps
repeatedly enter an IL-7 refractory, non-
proliferative phase, where RAG expres-
sion is induced? Attenuated IL-7 signaling
has been reported in B cells even though
they continue to express the IL-7 recep-
tor. If so, it would be interesting to identify
the intracellular components responsible
for regulating IL-7 signaling in this way. Al-
ternatively, rearrangement of the light-
chain genes may require higher amounts
of RAG than does that of the heavy-chain
genes, and the IL-7 inhibition of RAG ex-
pression may be concentration depen-
dent. Finally, in early pre-B cells, IL-7
and pre-BCR signaling may synergize to
dampen Rag transcription to a greater
extent than IL-7 signaling alone.
In conclusion, the work described by
Johnson et al. (2008) provides exciting in-
sight into the function of IRF-4 as a regula-
tory node in the transition of pre-B to im-
mature B cells. One important role of this
transcription factor, which is upregulated
by pre-BCR signals, consists in the down-
regulation of the surrogate light-chain
genes and the activation of the 30 k and
l enhancers, resulting in the initiation of
light-chain gene rearrangement and posi-
tioning of the loci away from heterochro-
matin. Another unexpected function of
IRF-4 appears to involve the induced ex-
pression of chemokine receptors, which
could help pre-B cells to move away
from IL-7-producing stromal cells. This
cell migration would lead to an attenua-
tion of IL-7 signaling and to enhanced
binding of E2A to the intronic k and Rag
enhancers.
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In this issue of Immunity, He et al. (2008) establish the logic and circuitry that determine CD4-CD8 lineage
specification. It all comes down to an eighty base pair silencer switch.Developmental contingencies are end-
lessly fascinating.There’ssomethingabout
a circuit that measures small differences
and accurately amplifies them into an
error-free outcome. Contingencies repre-
sent the oppositeof chaos and the epitome
of robustness. In developmental immunol-
ogy, none has received more attention
than the CD4 versus CD8 T cell lineagecommitment, perhaps because it is inter-
twined with the storied concepts of MHC
restriction and thymic selection.
The principles of lineage commitment
consist of a basis for the decision, the
conceptual underlying logic, and the ana-
log circuitry used the compute an all-
or-none result. We understand the first, I
propose that an understanding of the sec-Immunond is close at hand, and with recent
breakthroughs we have the tools to un-
derstand the third. The first is easy; the
specificity of the receptor (TCR) deter-
mines the outcome of the differentiation
pathway—but what is the logic? Do class
II- and class I-specific TCRs transmit
quantifiably different signals (instruction),
or does the developing thymocyte ventureity 28, March 2008 ª2008 Elsevier Inc. 297
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Previewsa guess and survive or not depending on
its accuracy (stochastic selection)? These
two models were initially proposed, each
was tested successfully, and each had
its proponents. As we might have pre-
dicted from similar debates in science,
the truth has elements of each.
A clue came from an analysis of MHC
class II-deficient mice. Flow cytometry
showed the lesion correlated with an
absence of mature CD4+ T cells but with
one curious finding. Although there were
no developing thymocytes that displayed
the CD4+CD8 phenotype, there was
a stubbornly persistent CD4+CD8lo popu-
lation. The inference was that this popula-
tion had abortively attempted the wrong
pathway, and this was said to be evidence
for selection. The observation was highly
influential in that it gave rise to a field
devoted entirely to ever-more-detailed
analyses of the iconic CD4 versus CD8
bivariant FACS plot. Thymocyte subsets,
based on graded CD4 and CD8 expres-
sion, were finely dissected into intermedi-
ate steps with vectored trajectories, and
there arose a new generation of models
describing asymmetric signaling require-
ments and default pathways. Still, none
was rigorously tested.
A breakthrough came in the form of the
kinetic signaling model, which is a decep-
tively simple but conceptually distinct var-
iation of all previous notions of CD4-CD8
lineage commitment (Singer, 2002). The
idea is that recognition of a ligand by
CD4+CD8+ thymocytes results in positive
selection. This, in turn, causes a reduction
in the intensity of CD8 expression that can
be mapped, in part, to the E8III enhancer
active during the CD4+CD8+ stage but
turned off upon positive selection (He-
drick, 2002). The idea is that continuous
signaling after positive selection denotes
the recognition of MHC class II, whereas
signaling that wanes as a result of a loss
of CD8 is evidence for the recognition of
MHC class I. Evidence in support of this
is that expression of CD4 under control
of the E8III enhancer, resulting in abortive
MHC class II-mediated signaling, causes
a lineage-commitment reversal (Sarafova
et al., 2005).
That leaves only the circuitry. The tran-
scription factor, GATA-3, is necessary
for CD4+ T cell development, but in its ab-
sence, there is no lineage redirection (Her-
nandez-Hoyos et al., 2003). The HMG-
containing factor, Tox (thymus HMG298 Immunity 28, March 2008 ª2008 Elseviebox), now appears to be essential for the
transition from CD4+CD8+ to the
CD4+CD8lo stage of development, and
although no CD4+ T cells arise in its ab-
sence, CD8+ T cell development is almost
normal (Aliahmad and Kaye, 2008). I sus-
pect that this is an indication that the
kinetic-signaling model is still incomplete.
The analysis of Runx1- and Runx3-defi-
cientmice showed that they arenecessary
forCD8+ lineagedevelopment anddirectly
affect the silencer activity of the Cd4 gene
(Taniuchi et al., 2002). The Runx mole-
cules are surely part of the lineage-speci-
fication network.
The spectacular discovery of a single
transcription factor that is necessary and
sufficient for CD4 lineage commitment
now forms the basis for a detailed de-
scription of the circuitry. One group found,
by chance (but with enlightened insight),
a mouse mutation, termed HD (T helper
deficient), lacking CD4+CD8 thymocytes
and T cells. Through genetics and analysis
by transgenesis, they mapped the muta-
tion to a single base in the DNA binding
domain of a transcription factor desig-
nated as ThPOK, but known alternatively
as c-Krox, Zfp67, and the official symbol,
Zbtb7b (zinc finger and BTB domain
containing 7B) (He et al., 2005). Another
group independently identified this line-
age-commitment factor from a differential
gene expression analysis of CD4+ and
CD8+ T cells (Sun et al., 2005). Zbtb7b is
first seen in the CD4+CD8lo subset of
thymocytes, and in HD mice (predicted
to be a Zbtb7b loss of function), MHC
class II-specific thymocytes incorrectly
differentiate into the CD8+ T cell lineage.
Moreover, enforced expression of Zbtb7b
in thymocytes causes MHC class I-spe-
cific cells to incorrectly differentiate into
the CD4+ T cell lineage. Zbtb7b is thus
necessary and sufficient for CD4 lineage
specification, and from this arises the
principle that positive selection is sepa-
rate from lineage commitment. Work is
now centered on identifying the down-
stream targets of Zbtb7b, and also
characterizing its own cis-acting tran-
scriptional regulation—the bottoms-up
approach taken to another stage (He-
drick, 2002). Along with another recently
published article (Setoguchi et al., 2008),
work by He et al. (2008) in this issue of
Immunity at once reinforces the kinetic
signaling model as a principle of CD4-
CD8 lineage specification and focuses at-r Inc.tention on a silencer-enhancer governing
Zbtb7b expression.
The report by He et al. (2008) is really
two related studies. In the first, they
sought to establish a basis for their previ-
ous observation that Zbtb7b is first ex-
pressed at the proposed lineage-commit-
ment step—CD4+CD8lo. The prediction
was that strong or extended signaling is
the origin this difference, and they
showed this by treatment of MHC class
II-deficient mice with antibody specific
for TCRb. The result was an induction
of Zbtb7b in CD4+CD8lo cells and the ap-
pearance of CD4+CD8 thymocytes. This
result is an affirmation that continued
signaling at this all-important stage, re-
gardless of its origin, is necessary for
CD4 lineage commitment. One could say
that MHC class II-mediated signaling is
stronger at this juncture and therefore
instructive, but that misses the essence
of the logic. This experiment is also telling
in that positive selection requires MHC
recognition because Lck is entirely bound
by CD4 and CD8 (Van Laethem et al.,
2007). Given that anti-TCRb is unlikely to
coordinate the inclusion of CD4 (and it at-
tendant Lck), I infer that signaling leading
to lineage commitment is different from
that required for positive selection.
To distinguish between the requirement
for strong or extended signaling at the lin-
eage-commitment stage, He et al. (2008)
produced HD;B2m/ mice and analyzed
the CD4+CD8lo population. Placing these
cells into culture presumably interrupts
TCR-CD4 signaling, and the result was
that Zbtb7b disappeared and the cells
expressed CD8. Furthermore, Zbtb7b
expression was rescued by the addition
of antibody specific for CD3.With caveats
concerning thymocyte development in
culture, this is consistent with the require-
ment for continued TCR-mediated signal-
ing at this decision stage in order to
maintain CD4 lineage commitment. The
class of MHC recognition is unimportant;
rather, it is only the extension of signaling
to maintain Zbtb7b expression (Figure 1).
In the second part, He et al. (2008) ana-
lyzed the cis-acting regulatory sequences
needed for Zbtb7b expression. Although
expression is mediated by multiple en-
hancer-like sequences (Figure 1), the
most interesting facet of the work was
the identification of a 50 distal sequence
that has characteristics of a silencer and
enhancer. Deletion of this distal response
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Previewselement (DRE)causedreporter
expression in both CD4 and
CD8 lineages, yet, a sequence
or sequences in this region
also functioned as an en-
hancer largely restricted to
the CD4+CD8lo stage. This
would appear to be further ev-
idence that the CD4+CD8lo
stage is a truly distinct subset
along the T cell developmental
pathway.
A region of 300 bp near the
DRE was found to be con-
served in mammals and mar-
supials and contains motifs
predicted to bind Gata,
Runx, NFkB, and E-box
factors. After deletion mu-
tants were generated and
then tested with their DRE-
deleted reporter construct,
the Gata, Runx, and E-box
sites appeared to be irrele-
vant, and they defined an 80
bp region important for si-
lencing. Analysis of multiple
founders was consistent with weak
silencing outside the 80 bp region, and
thus a contribution by Runx or Gata was
not entirely eliminated. Through this ele-
gant, extensive, in vivo analysis, He et al.
(2008) appear to have defined a silencer
element that is controlled by an unknown
transcription factor or factors that em-
body CD4-CD8 lineage specification.
Yet, there is one complication.
In a recent report, Setoguchi et al.
(2008) described their continued analysis
of Runx as a repressor important for CD4-
CD8 lineage specification. A number of
transcriptional repressors, including the
Runt-Runx family, act by way of a core-
pressor known as Groucho. In addition
to conditional mutations in Runx1 and
Runx3 previously analyzed, these investi-
gators produced a Runx1 mutant lacking
the conserved VWRPY Groucho-interac-
tion motif at the carboxyl terminus. Ana-
lyzing mice with various combinations of
Runx genes deleted or mutated, they
found that Runx3-deficient mice with a
Runx1-VWRPY mutation completely
lacked CD8+ T cells—even in the absence
of MHC class II genes.
The investigators used ChIP-on-chip to
find sequences in the Zbtb7b locus that
bind to the Runx binding partner, Cbfb2.
Two were found and one corresponded
with the DRE. Setoguchi et al. (2008)
similarly found the deletion of this gene
element derepressed the Zbtb7b locus
in CD8 T cells, but differing from the
above results, the Runx sites were neces-
sary for efficient silencer activity. On the
other hand, these Runx complexes were
shown to bind even in cells expressing
Zbtb7b, and therefore, Runx binding
does not itself confer the specificity of
silencing.
Although they differ in a role for Runx-
Groucho-mediated repression, the two
studiesestablishverysimilar and important
principles underlying CD4-CD8 lineage
specification. Zbtb7b is regulated by an
enhancer-silencer element in the distal-
most region of the upstream regulatory
region, and it actsat thecritical
CD4+CD8lo stage of develop-
ment. The element includes
Runx sites, but importantly,
there is a critical factor yet to
be identified. The tools are
now at hand to understand
CD4-CD8 lineage specifica-
tion to a degree previously
only achieved with saturating
mutagenesis screens in sim-
ple metazoans. As referred to
above, there are probably
principles yet to be discov-
ered, or as Groucho himself
said, ‘‘Those are my principles
. if youdon’t like themI’vegot
others.’’
REFERENCES
Aliahmad, P., and Kaye, J. (2008).
J. Exp. Med. 205, 245–256.
He, X., He, X., Dave, V.P., Zhang, Y.,
Hua, X., Nicolas, E., Xu, W., Roe,
B.A., and Kappes, D.J. (2005).
Nature 433, 826–833.
He et al., 2008He, X., Park, K., Wang, H., He, X.,
Zhang, Y., Hua, X., Li, Y., and Kappes, D.J.
(2008). Immunity 28, this issue, 346–358.
Hedrick, S.M. (2002). Immunity 16, 619–622.
Hernandez-Hoyos, G., Anderson, M.K., Wang, C.,
Rothenberg, E.V., and Alberola-Ila, J. (2003).
Immunity 19, 83–94.
Sarafova, S.D., Erman, B., Yu, Q., Van Laethem, F.,
Guinter, T., Sharrow, S.O., Feigenbaum, L., Wildt,
K.F., Ellmeier, W., and Singer, A. (2005). Immunity
23, 75–87.
Setoguchi, R., Tachibana, M., Naoe, Y., Muroi, S.,
Akiyama, K., Tezuka, C., Okuda, T., and Taniuchi, I.
(2008). Science 319, 822–825.
Singer, A. (2002). Curr. Opin. Immunol. 14, 207–
215.
Sun, G., Liu, X., Mercado, P., Jenkinson, S.R.,
Kypriotou, M., Feigenbaum, L., Galera, P., and
Bosselut, R. (2005). Nat. Immunol. 6, 373–381.
Taniuchi, I., Osato, M., Egawa, T., Sunshine, M.J.,
Bae, S.C., Komori, T., Ito, Y., and Littman, D.R.
(2002). Cell 111, 621–633.
Van Laethem, F., Sarafova, S.D., Park, J.H., Tai, X.,
Pobezinsky, L., Guinter, T.I., Adoro, S., Adams, A.,
Sharrow, S.O., Feigenbaum, L., and Singer, A.
(2007). Immunity 27, 735–750.
Figure 1. Lineage Commitment Depends on a Zbtb7b Silencer
The lineage-commitment step takes place subsequent to positive selection at
a stage in which cells express a CD4+CD8lo phenotype. With continued signal-
ing through the TCR, the DRE silencer activity is blocked and enhancer activity
activated; Zbtb7b resolves CD4 lineage commitment through repression and
activation of lineage-specific genes. Discontinued signaling through the TCR
results in Groucho-dependent DRE silencer activity and no Zbtb7b expres-
sion, and cells commit to the CD8 lineage. DRE denotes distal regulatory ele-
ment, GTE denotes general T lymphoid element, and PRE denotes proximal
regulatory element.Immunity 28, March 2008 ª2008 Elsevier Inc. 299
